Načítá se...
Designing Functionally Selective Noncatechol Dopamine D(1) Receptor Agonists with Potent In Vivo Antiparkinsonian Activity
Dopamine receptors are important G protein-coupled receptors (GPCRs) with therapeutic opportunities for treating Parkinson’s Disease (PD) motor and cognitive deficits. Biased D(1) dopamine ligands that differentially activate G protein over β-arrestin recruitment pathways are valuable chemical tools...
Uloženo v:
| Vydáno v: | ACS Chem Neurosci |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6785188/ https://ncbi.nlm.nih.gov/pubmed/31387346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.9b00410 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|